Stay updated on Nivolumab Combinations in EGFR+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.

Latest updates to the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page
- Check5 days agoChange DetectedA new page revision label, v3.5.4, was added and the previous label, v3.5.3, was removed in the Record History, indicating an update to the page’s release version.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s displayed software/revision version is updated from v3.5.2 to v3.5.3. This reflects a site/version change rather than an update to the trial’s record details.SummaryDifference0.0%

- Check34 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.3 was added to the history and revision: v3.4.2 was removed.SummaryDifference0.0%

- Check98 days agoChange DetectedNew Revision: v3.4.2 was added and the funding-status notice (and Revision: v3.4.1) was removed, reflecting routine site maintenance. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Combinations in EGFR+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.